Positive Behavior Management Toolkit for Attention Deficit Hyperactivity Disorder Symptoms

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Children's Hospital of Philadelphia, Philadelphia, PA
Attention Deficit Hyperactivity Disorder Symptoms+2 More
Positive Behavior Management Toolkit - Behavioral
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to pilot test for feasibility and initial promise an implementation strategy resource package that aims to support teachers in using behavioral classroom management interventions for children with hyperactive, inattentive, or impulsive behaviors. Participating teachers will be randomized to receive the resource package or support as usual and the research team will examine, a) teacher implementation of behavioral classroom interventions and b) mental health outcomes for enrolled children.

Eligible Conditions

  • Attention Deficit Hyperactivity Disorder Symptoms

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Attention Deficit Hyperactivity Disorder Symptoms

Study Objectives

8 Primary · 5 Secondary · Reporting Duration: Baseline, midpoint (i.e., up to 7 weeks from resource package receipt), endpoint (i.e, at least 8 weeks from resource package receipt)

Week 8
Change in Academic Productivity
Change in Academic Success
Change in Homework Performance
Change in Student-Teacher Relationship
Change in caregiver-reported ADHD Symptoms
Change in caregiver-reported Child Functional Impairment
Change in engagement and Disruptive Direct Behavior Ratings
Change in teacher-reported ADHD Symptoms
Change in teacher-reported Child Functional Impairment
Week 8
Change in observed teacher use of behavioral classroom management interventions
Potential mediators of teacher implementation outcomes
Week 8
Acceptability of Intervention Measure (AIM)
Feasibility of Intervention Measure
Intervention Appropriateness Measure (IAM)

Trial Safety

Safety Progress

1 of 3

Other trials for Attention Deficit Hyperactivity Disorder Symptoms

Trial Design

2 Treatment Groups

Control Group
1 of 2
Implementation Resource Package Group
1 of 2
Active Control
Experimental Treatment

90 Total Participants · 2 Treatment Groups

Primary Treatment: Positive Behavior Management Toolkit · No Placebo Group · N/A

Implementation Resource Package Group
Behavioral
Experimental Group · 1 Intervention: Positive Behavior Management Toolkit · Intervention Types: Behavioral
Control GroupNoIntervention Group · 1 Intervention: Control Group · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, midpoint (i.e., up to 7 weeks from resource package receipt), endpoint (i.e, at least 8 weeks from resource package receipt)
Closest Location: Children's Hospital of Philadelphia · Philadelphia, PA
Photo of Philadelphia 1Photo of Philadelphia 2Photo of Philadelphia 3
2011First Recorded Clinical Trial
1 TrialsResearching Attention Deficit Hyperactivity Disorder Symptoms
659 CompletedClinical Trials

Who is running the clinical trial?

Children's Hospital of PhiladelphiaLead Sponsor
640 Previous Clinical Trials
7,846,794 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,489 Previous Clinical Trials
1,765,820 Total Patients Enrolled
Gwendolyn M Lawson, PhDPrincipal InvestigatorChildren's Hospital of Philadelphia/University of Pennsylvania Perelman School of Medicine

Eligibility Criteria

Age Any Age · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are a K-5 teacher at a participating school within the School District of Philadelphia.
You are in a K-5 class of a participating teacher.
You are a teacher at a participating school.\n
You have given informed consent.
You have the mental capacity to provide consent for the participation of child in the study and for their own participation in the study.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.